Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gossamer Bio, Inc. - Common Stock
(NQ:
GOSS
)
0.8400
-0.0009 (-0.11%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
954,140
Open
0.8300
Bid (Size)
0.8103 (13)
Ask (Size)
0.8500 (5)
Prev. Close
0.8409
Today's Range
0.7902 - 0.8499
52wk Range
0.4993 - 1.600
Shares Outstanding
75,993,532
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 12, 2024
Via
Benzinga
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 11, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Performance
YTD
-13.40%
-13.40%
1 Month
+20.76%
+20.76%
3 Month
-16.00%
-16.00%
6 Month
+1.68%
+1.68%
1 Year
-3.24%
-3.24%
More News
Read More
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
November 07, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 07, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 02, 2024
Via
Benzinga
Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024
August 26, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
GOSS Stock Earnings: Gossamer Bio Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
Via
InvestorPlace
Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
August 12, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
June 25, 2024
Via
Benzinga
Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
June 25, 2024
Via
Benzinga
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 21, 2024
Via
Benzinga
The Penny Stock Pundits: 3 Companies Poised to Become the Talk of Wall Street
June 13, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 11, 2024
Via
Benzinga
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
May 14, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
May 13, 2024
Via
Benzinga
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
GOSS Stock Earnings: Gossamer Bio Misses EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
May 06, 2024
Via
Benzinga
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
May 06, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
May 03, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
March 12, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.